154 related articles for article (PubMed ID: 12640307)
1. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Maes BD; Dalle I; Geboes K; Oellerich M; Armstrong VW; Evenepoel P; Geypens B; Kuypers D; Shipkova M; Geboes K; Vanrenterghem YF
Transplantation; 2003 Mar; 75(5):665-72. PubMed ID: 12640307
[TBL] [Abstract][Full Text] [Related]
2. Steatorrhoea complicating post-infectious diarrhoea in a renal transplant patient on mycophenolate mofetil therapy.
Tagboto S; Akhtar F
Clin Exp Nephrol; 2009 Apr; 13(2):182-184. PubMed ID: 19066719
[TBL] [Abstract][Full Text] [Related]
3. Patterns of injury in mycophenolate mofetil-related colitis.
Al-Absi AI; Cooke CR; Wall BM; Sylvestre P; Ismail MK; Mya M
Transplant Proc; 2010 Nov; 42(9):3591-3. PubMed ID: 21094821
[TBL] [Abstract][Full Text] [Related]
4. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.
Papadimitriou JC; Cangro CB; Lustberg A; Khaled A; Nogueira J; Wiland A; Ramos E; Klassen DK; Drachenberg CB
Int J Surg Pathol; 2003 Oct; 11(4):295-302. PubMed ID: 14615824
[TBL] [Abstract][Full Text] [Related]
5. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?
Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW
Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769
[TBL] [Abstract][Full Text] [Related]
6. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
[TBL] [Abstract][Full Text] [Related]
7. Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis.
Frei P; Weber A; Geier A; Mertens JC; Kohler S; Rogler G; Müllhaupt B
Transpl Infect Dis; 2011 Aug; 13(4):416-8. PubMed ID: 21615846
[TBL] [Abstract][Full Text] [Related]
8. De novo Crohn's disease in a renal transplant recipient.
Halim MA; Said T; Nair P; Schmidt I; Hassan A; Johny KV; Al-Muzairai I; Samhan M; Nampoory MR; Al-Mousawi M
Transplant Proc; 2007 May; 39(4):1278-9. PubMed ID: 17524953
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between dose of mycophenolate mofetil and the occurrence of cytomegalovirus infection and diarrhea in renal transplant recipients].
Toda T; Motoki T; Kurosawa N; Owada E; Achiwa K; Yuhki Y; Tadano K; Takahashi Y; Shimoda N; Shindo J; Harada H; Seki T; Hirano T
Yakugaku Zasshi; 2005 Feb; 125(2):177-85. PubMed ID: 15684572
[TBL] [Abstract][Full Text] [Related]
11. Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium.
Kamar N; Oufroukhi L; Faure P; Ribes D; Cointault O; Lavayssiere L; Nogier MB; Esposito L; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Oct; 20(10):2231-6. PubMed ID: 16046517
[TBL] [Abstract][Full Text] [Related]
12. Crohn's-like changes in the colon due to mycophenolate?
Dalle IJ; Maes BD; Geboes KP; Lemahieu W; Geboes K
Colorectal Dis; 2005 Jan; 7(1):27-34. PubMed ID: 15606581
[TBL] [Abstract][Full Text] [Related]
13. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
14. The use of mycophenolate mofetil suspension in pediatric renal allograft recipients.
Bunchman T; Navarro M; Broyer M; Sherbotie J; Chavers B; Tönshoff B; Birk P; Lerner G; Lirenman D; Greenbaum L; Walker R; Zimmerhackl LB; Blowey D; Clark G; Ettenger R; Arterburn S; Klamerus K; Fong A; Tang H; Thomas S; Ramos E
Pediatr Nephrol; 2001 Dec; 16(12):978-84. PubMed ID: 11793083
[TBL] [Abstract][Full Text] [Related]
15. [Infectious complications in using mofetil micofenolate in patients with renal allotransplant].
Prokopenko EI; Shcherbakova EO; Vatazin AV; Kruglov EE; Pasov SA; Budnikova NE; Agafonova SG; Rusanova EV
Ter Arkh; 2005; 77(1):67-72. PubMed ID: 15759459
[TBL] [Abstract][Full Text] [Related]
16. Intestinal infection at onset of mycophenolic acid-associated chronic diarrhea in kidney transplant recipients.
von Moos S; Cippà PE; Wüthrich RP; Mueller TF
Transpl Infect Dis; 2016 Oct; 18(5):721-729. PubMed ID: 27502733
[TBL] [Abstract][Full Text] [Related]
17. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil-induced colitis in children.
Phatak UP; Seo-Mayer P; Jain D; Selbst M; Husain S; Pashankar DS
J Clin Gastroenterol; 2009; 43(10):967-9. PubMed ID: 19609219
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for maintenance therapy in kidney transplantation.
Gonwa TA
Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient.
Patra S; Vij M; Sukanya B; Kapoor D
Indian J Pathol Microbiol; 2012; 55(4):506-8. PubMed ID: 23455789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
